Botoxone.com - SEO Checker

Overview of the SEO Check
Meta information
80% 
Page quality
29% 
Page structure
58% 
Link structure
82% 
Server
99% 
External factors
100% 
SEO Score
Response time
0.41 s
File size
182.50 kB
Words
6191
Media files
11
Number of links
43 internal / 21 external

Task list of SEO Improvements

Meta specifications

Title
(Critically important)
HOME | BOTOX ONE® | BOTOX® (onabotulinumtoxinA)
There are word repetitions in the page title.
The length of the page title is perfect. (519 pixels out of 580 max pixel length)
Meta description
(Critically important)
Welcome to BOTOX ONE®. We're committed to helping your practice serve patients by offering the tools and resources you and your staff need. Click here for full Safety and Prescribing Information, including Boxed Warning
The meta description is too long: 1381 pixels from max. 1000 pixels. Optimize description
Crawlability
(Critically important)
There are no problems in accessing the website.
Canonical URL
(Important)
No canonical link is specified.
Language
(Somewhat important)
Language detected in text: en
Language defined in HTML: en-us
Language defined in meta tags: en
Server location: United States of America
There are different language information within the page markup.
The following language is defined by HTML: en
Alternate/Hreflang Links
(Somewhat important)
There are no alternate links specified on this page.
Other meta tags
(Somewhat important)
There is no rel next meta tag on this page.
There is no rel prev meta tag on this page.
Domain
(Somewhat important)
The domain is no subdomain.
The domain length is good.
The domain does not contain non-latin characters.
Page URL
(Somewhat important)
No parameters were found in the URL.
No session ID was found in the URL.
The URL does not have too many subdirectories.
Charset encoding
(Somewhat important)
The charset encoding (UTF-8) is set correctly.
Doctype
(Nice to have)
The doctype HTML 5 is set correctly.
The doctype is placed at first in the HTML code.
Favicon
(Nice to have)
The favicon is linked correctly.

Meta tags

NameValue
viewportwidth=device-width, initial-scale=1
audienceClinicians and Staff;Patients;Practice Staff
practice-resourcesPatient Materials;Provider Tools;Office Tools
languagetagEnglish;Spanish
servicesReimbursement
insuranceandsavingsBOTOX® Savings Program
keywordsPatient Materials,BOTOX® Savings Program,Provider Tools,Practice Staff,Reimbursement,Spanish,Patients,Office Tools,Clinicians and Staff,English,Indication Reset
descriptionWelcome to BOTOX ONE<sup>®</sup>. We're committed to helping your practice serve patients by offering the tools and resources you and your staff need. Click here for full Safety and Prescribing Information, including Boxed Warning
languageen
countryUS
pagenameHOME | BOTOX ONE® | BOTOX® (onabotulinumtoxinA)
templatenamefull-width-content-page
pageurl/
franchiseCross Franchise (Cross)
content-journeybrand benefit
patient-journeyEmpty
forcedmodaloverlayno
indication-idEmpty
sitenameBotoxone
globalisiUS-BTX-220125
epassnumberUS-BTX-230107
langen-us
content-typetext/html; charset=UTF-8
charsetutf-8

Test up to 1.000 webpages of botoxone.com with our free plan!

Try For Free
No trial. It's just free!

Page quality

Content
(Critically important)
Some words from the page title are not used within the pages content
The content of this page is too large (6191 words). Maybe the content could be divided into several pages.
There are 116 text duplicates on this page:
  • Duplicate 1: WARNING: DISTANT SPREAD OF TOXIN EFFECT Postmarketing reports indicate...
  • Duplicate 2: BOTOX for injection is indicated for the treatment of overactive bladd...
  • Duplicate 3: BOTOX is indicated for the treatment of urinary incontinence due to de...
  • Duplicate 4: BOTOX is indicated for the treatment of neurogenic detrusor overactivi...
  • Duplicate 5: BOTOX is indicated for the prophylaxis of headaches in adult patients ...
  • Duplicate 6: Safety and effectiveness have not been established for the prophylaxis...
  • Duplicate 7: BOTOX has not been shown to improve upper extremity functional abiliti...
  • Duplicate 8: BOTOX is indicated for the treatment of adults with cervical dystonia ...
  • Duplicate 9: BOTOX is indicated for the treatment of strabismus and blepharospasm a...
  • Duplicate 10: BOTOX is indicated for the treatment of severe primary axillary hyperh...
  • Duplicate 11: The safety and effectiveness of BOTOX for hyperhidrosis in other body ...
  • Duplicate 12: Safety and effectiveness of BOTOX have not been established for the tr...
  • Duplicate 13: BOTOX is contraindicated in the presence of infection at the proposed ...
  • Duplicate 14: BOTOX is contraindicated for intradetrusor injection in patients with ...
  • Duplicate 15: No definitive serious adverse event reports of distant spread of toxin...
  • Duplicate 16: Lack of Interchangeability Between Botulinum Toxin Products The potenc...
  • Duplicate 17: Serious adverse reactions, including excessive weakness, dysphagia, an...
  • Duplicate 18: Serious and/or immediate hypersensitivity reactions have been reported...
  • Duplicate 19: Individuals with peripheral motor neuropathic diseases, amyotrophic la...
  • Duplicate 20: Treatment with BOTOX and other botulinum toxin products can result in ...
  • Duplicate 21: Patients with compromised respiratory status treated with BOTOX for sp...
  • Duplicate 22: Reduced blinking from BOTOX injection of the orbicularis muscle can le...
  • Duplicate 23: During the administration of BOTOX for the treatment of strabismus, re...
  • Duplicate 24: Bronchitis was reported more frequently as an adverse reaction in adul...
  • Duplicate 25: Autonomic dysreflexia associated with intradetrusor injections of BOTO...
  • Duplicate 26: BOTOX increases the incidence of UTI. Clinical trials for overactive b...
  • Duplicate 27: Due to the risk of urinary retention, treat only patients who are will...
  • Duplicate 28: In patients who are not catheterizing, PVR urine volume should be asse...
  • Duplicate 29: In clinical trials, 6.5% of patients (36/552) initiated CIC for urinar...
  • Duplicate 30: Patients with diabetes mellitus treated with BOTOX were more likely to...
  • Duplicate 31: In clinical trials, 30.6% of adult patients (33/108) who were not usin...
  • Duplicate 32: Among adult patients not using CIC at baseline, those with multiple sc...
  • Duplicate 33: This product contains albumin, a derivative of human blood. Based on e...
  • Duplicate 34: Adverse reactions to BOTOX for injection are discussed in greater deta...
  • Duplicate 35: The most frequently reported adverse reactions for overactive bladder ...
  • Duplicate 36: A higher incidence of UTI was observed in patients with diabetes melli...
  • Duplicate 37: The incidence of UTI increased in patients who experienced a maximum P...
  • Duplicate 38: The most frequently reported adverse reactions within 12 weeks of BOTO...
  • Duplicate 39: The following adverse event rates were reported at any time following ...
  • Duplicate 40: The most frequently reported adverse reactions during the 12 weeks fol...
  • Duplicate 41: The most common adverse reactions in patients who received BOTOX 6 Uni...
  • Duplicate 42: These patients were not adequately managed with at least one anticholi...
  • Duplicate 43: The most frequently reported adverse reactions following injection of ...
  • Duplicate 44: Severe worsening of migraine requiring hospitalization occurred in app...
  • Duplicate 45: The most frequently reported adverse reactions following injection of ...
  • Duplicate 46: The most frequently reported adverse reactions following injection of ...
  • Duplicate 47: The most frequently reported adverse reactions following injection of ...
  • Duplicate 48: The most frequently reported adverse reactions following injection of ...
  • Duplicate 49: The most frequently reported adverse reactions following injection of ...
  • Duplicate 50: The most frequently reported adverse reactions following injection of ...
  • Duplicate 51: The most frequently reported adverse events following injection of BOT...
  • Duplicate 52: The most frequently reported adverse events (3%-10% of adult patients)...
  • Duplicate 53: Adverse reactions that have been identified during postapproval use of...
  • Duplicate 54: There have been spontaneous reports of death, sometimes associated wit...
  • Duplicate 55: Co-administration of BOTOX and other agents interfering with neuromusc...
  • Duplicate 56: Please see BOTOX® full Prescribing Information, including Boxed Warnin...
  • Duplicate 57: WARNING: DISTANT SPREAD OF TOXIN EFFECT Postmarketing reports indicate...
The average number of words per sentence of 33.52 words is high.
32.3% of the text are stop words.
The page contains a listing, which indicates a good text layout.
121 paragraphs were found on this page.
No placeholders texts or images were found.
Frames
(Critically important)
This page does not use a frameset.
Mobile optimization
(Somewhat important)
A viewport "width=device-width, initial-scale=1" is provided.
At least one Apple touch icon is specified.
Bold and strong tags
(Somewhat important)
Some tags are too long. With 1011 characters this one is longer than 70 characters:
"warning: distant spread of toxin effect postmarketing reports indicate that the effects of botox and a..."
The following tag is repeated too often: warning: distant spread of toxin effect postmarketing reports indicate that the effects of botox and a...
Image SEO
(Somewhat important)
7 images have no alt attribute. The content of alt attributes is used by search engines.
Social Networks
(Nice to have)
There are only a few social sharing widgets on the page. Make your website popular in social networks with social sharing widgets.
Additional markup
(Nice to have)
No additional page markup was found.
HTTPS
(Somewhat important)
This website uses HTTPS to protect privacy and integrity of the exchanged data.
All included files are also transferred via HTTPS.

Page structure

H1 heading
(Critically important)
There is no H1 heading specified.
Headings
(Important)
Some headings occur twice on the page.
The structure of headings is missing one or more levels. Do not skip heading levels.
There are 96 headings on the page. The amount of headings should be in a more proper relation to the amount of text.

Heading structure

Heading levelContent
H2 Is your BOTOX® authentic and FDA approved for use in US?
H2 Notify your eligible patients to enroll in the BOTOX® Savings Program
H2 See key information in a single location
H2 Made for your team
H2 Download clinical, office, and patient resources
H2 Assistance from AbbVie experts
H3 BOTOX® IMPORTANT INFORMATION
H3 IMPORTANT SAFETY INFORMATION, INCLUDING BOXED WARNING
H3 INDICATIONS
H3 Adult Bladder Dysfunction
H3 Pediatric Detrusor Overactivity Associated With a Neurologic Condition
H3 Chronic Migraine
H3 Limitations of Use
H3 Spasticity
H3 Limitations of Use Duplicate text
H3 Cervical Dystonia
H3 Blepharospasm and Strabismus
H3 Primary Axillary Hyperhidrosis
H3 Limitations of Use Duplicate text
H3 IMPORTANT SAFETY INFORMATION (continued)
H3 CONTRAINDICATIONS
H3 WARNINGS AND PRECAUTIONS
H3 Serious Adverse Reactions With Unapproved Use
H3 Hypersensitivity Reactions
H3 Increased Risk of Clinically Significant Effects With Preexisting Neuromuscular Disorders
H3 Dysphagia and Breathing Difficulties
H3 Pulmonary Effects of BOTOX in Patients With Compromised Respiratory Status Treated for Spasticity or for Detrusor Overactivity Associated With a Neurologic Condition
H3 Corneal Exposure and Ulceration in Patients Treated With BOTOX for Blepharospasm
H3 Retrobulbar Hemorrhages in Patients Treated With BOTOX for Strabismus
H3 Bronchitis and Upper Respiratory Tract Infections in Patients Treated for Spasticity
H3 Autonomic Dysreflexia in Patients Treated for Detrusor Overactivity Associated With a Neurologic Condition
H3 Urinary Tract Infections in Patients With Overactive Bladder
H3 Urinary Retention in Adults Treated for Bladder Dysfunction
H3 Human Albumin and Transmission of Viral Diseases
H3 ADVERSE REACTIONS
H3 Overactive Bladder
H3 Adult Detrusor Overactivity Associated With a Neurologic Condition
H3 Pediatric Detrusor Overactivity Associated With a Neurologic Condition Duplicate text
H3 Chronic Migraine Duplicate text
H3 Adult Upper Limb Spasticity
H3 Adult Lower Limb Spasticity
H3 Pediatric Upper Limb Spasticity
H3 Pediatric Lower Limb Spasticity
H3 Cervical Dystonia Duplicate text
H3 Blepharospasm
H3 Strabismus
H3 Primary Axillary Hyperhidrosis Duplicate text
H3 Postmarketing Experience
H3 DRUG INTERACTIONS
H3 IMPORTANT SAFETY INFORMATION, INCLUDING BOXED WARNING Duplicate text
H3 IMPORTANT SAFETY INFORMATION, INCLUDING BOXED WARNING Duplicate text
H3 IMPORTANT SAFETY INFORMATION, INCLUDING BOXED WARNING Duplicate text
H3 IMPORTANT SAFETY INFORMATION, INCLUDING BOXED WARNING Duplicate text
H3 BOTOX® IMPORTANT INFORMATION Duplicate text
H3 IMPORTANT SAFETY INFORMATION, INCLUDING BOXED WARNING Duplicate text
H3 INDICATIONS Duplicate text
H3 Adult Bladder Dysfunction Duplicate text
H3 Pediatric Detrusor Overactivity Associated With a Neurologic Condition Duplicate text
H3 Chronic Migraine Duplicate text
H3 Limitations of Use Duplicate text
H3 Spasticity Duplicate text
H3 Limitations of Use Duplicate text
H3 Cervical Dystonia Duplicate text
H3 Blepharospasm and Strabismus Duplicate text
H3 Primary Axillary Hyperhidrosis Duplicate text
H3 Limitations of Use Duplicate text
H3 IMPORTANT SAFETY INFORMATION (continued) Duplicate text
H3 CONTRAINDICATIONS Duplicate text
H3 WARNINGS AND PRECAUTIONS Duplicate text
H3 Serious Adverse Reactions With Unapproved Use Duplicate text
H3 Hypersensitivity Reactions Duplicate text
H3 Increased Risk of Clinically Significant Effects With Preexisting Neuromuscular Disorders Duplicate text
H3 Dysphagia and Breathing Difficulties Duplicate text
H3 Pulmonary Effects of BOTOX in Patients With Compromised Respiratory Status Treated for Spasticity or for Detrusor Overactivity Associated With a Neurologic Condition Duplicate text
H3 Corneal Exposure and Ulceration in Patients Treated With BOTOX for Blepharospasm Duplicate text
H3 Retrobulbar Hemorrhages in Patients Treated With BOTOX for Strabismus Duplicate text
H3 Bronchitis and Upper Respiratory Tract Infections in Patients Treated for Spasticity Duplicate text
H3 Autonomic Dysreflexia in Patients Treated for Detrusor Overactivity Associated With a Neurologic Condition Duplicate text
H3 Urinary Tract Infections in Patients With Overactive Bladder Duplicate text
H3 Urinary Retention in Adults Treated for Bladder Dysfunction Duplicate text
H3 Human Albumin and Transmission of Viral Diseases Duplicate text
H3 ADVERSE REACTIONS Duplicate text
H3 Overactive Bladder Duplicate text
H3 Adult Detrusor Overactivity Associated With a Neurologic Condition Duplicate text
H3 Pediatric Detrusor Overactivity Associated With a Neurologic Condition Duplicate text
H3 Chronic Migraine Duplicate text
H3 Adult Upper Limb Spasticity Duplicate text
H3 Adult Lower Limb Spasticity Duplicate text
H3 Pediatric Upper Limb Spasticity Duplicate text
H3 Pediatric Lower Limb Spasticity Duplicate text
H3 Cervical Dystonia Duplicate text
H3 Blepharospasm Duplicate text
H3 Strabismus Duplicate text
H3 Primary Axillary Hyperhidrosis Duplicate text
H3 Postmarketing Experience Duplicate text
H3 DRUG INTERACTIONS Duplicate text
Some internal links have dynamic parameters. All internal URLs, which are not marked as nofollow, should not contain dynamic parameters.
Some anchor texts are used more than once.
1 links don't have an anchor text.
The number of internal links is ok.
None of the anchor texts is too long.
There are 21 external links on this page.
LinkAttributesAnchor text
https://www.botoxone.com/Anchor Important Safety Information, Including Boxed Warning
http://www.allergan.com/assets...New window External Subdomain Full Prescribing Information
http://www.allergan.com/assets...New window External Subdomain Medication Guide
http://www.botox.com/New window External Subdomain Not an HCP? Go to Patient Site
https://www.botoxone.com/Anchor Text duplicate Important Safety Information, Including Boxed Warning
http://www.allergan.com/assets...New window External Subdomain Text duplicate Full Prescribing Information
http://www.allergan.com/assets...New window External Subdomain Text duplicate Medication Guide
http://www.botox.com/New window External Subdomain Text duplicate Not an HCP? Go to Patient Site
https://www.botoxone.com/IMG-ALT Botox Plus Logo
https://www.botoxone.com/Share Savings Program
/find-an-injectorFind an Injector
https://www.botoxone.com/registerSign up
https://www.botoxone.com/sign-inSign in
/dashboardMy Dashboard
/manage-accountManage account
/search-resultsNo Text
https://www.botoxone.com/Nofollow Home
/botox-servicesNofollow BOTOX® Services
https://www.allergandirect.com/New window External Subdomain Order BOTOX®
https://www.botoxonego.com/New window External Subdomain Manage Reimbursement
/find-an-injectorText duplicate Find an Injector
/request-a-repRequest a Rep
https://www.botoxone.com/faqsFAQ
/clinical-informationNofollow Clinical Information
/chronic-migraineChronic Migraine
/adult-spasticityAdult Spasticity
/pediatric-spasticityPediatric Spasticity
/cervical-dystoniaCervical Dystonia
/strabismusStrabismus
/blepharospasmBlepharospasm
https://www.botoxone.com/oabOveractive Bladder
/adult-ndoAdult Overactive Bladder due to a Neurologic Condition
/pediatric-ndoPediatric Overactive Bladder due to a Neurologic Condition
/hyperhidrosisSevere Primary Axillary Hyperhidrosis
/practice-resources?q=practice...Nofollow Practice Resources
/practice-resources?q=Patient ...Patient Materials
/practice-resources?q=Provider...Provider Tools
/practice-resources?q=Office T...Office Tools
/patient-access-and-supportNofollow Patient Access and Support
/patient-access-and-supportPatient Savings
/patient-access-and-supportInsurance Coverage
https://www.botoxone.com/Anchor Text duplicate Share Savings Program
/find-an-injectorText duplicate Find an Injector
https://www.botoxone.com/registerRegister
A-TITLE Register
/content/dam/botoxone/pdf/Trac...New window LEARN MORE
https://www.botoxone.com/registerText duplicate Register
A-TITLE Register
/practice-resourcesACCESS RESOURCES
/request-a-repREQUEST HELP
https://www.botoxone.com/registerREGISTER
https://www.rxabbvie.com/pdf/b...New window External Subdomain Prescribing Information
https://media.allergan.com/act...New window External Subdomain Text duplicate Medication Guide
https://www.rxabbvie.com/pdf/b...New window External Subdomain Text duplicate Prescribing Information
https://media.allergan.com/act...New window External Subdomain Text duplicate Medication Guide
https://www.botoxone.com/Text duplicate Home
https://www.botoxone.com/site-mapSite Map
https://www.abbvie.com/abbvie-...External Subdomain About AbbVie
https://www.abbvie.com/accessi...New window External Subdomain Accessibility Statement
https://www.abbvie.com/contact...New window External Subdomain Contact Us
https://www.abbvie.com/termsof...New window External Subdomain Terms of Use
https://privacy.abbvie/privacy...New window External Privacy Notice
https://abbviemetadata.my.site...New window External Subdomain Your Privacy Choices
https://www.abbvie.com/External Subdomain No Text
https://www.rxabbvie.com/pdf/b...New window External Subdomain Text duplicate Prescribing Information
https://media.allergan.com/act...New window External Subdomain Text duplicate Medication Guide

Server configuration

HTTP redirects
(Critically important)
This page redirects to "https://www.botoxone.com/"
HTTP header
(Important)
No X-Powered HTTP header is sent.
This page uses GZip for compressed data transmission.
Performance
(Somewhat important)
The page response time of 0.41 seconds is longer than the recommended limit of 0.4 seconds. A high response time unnecessarily slows down search engine crawling and results in bad user experience as well.
The file size of the HTML document is fine (183 kB).

HTTP Response Header

NameValue
content-typetext/html;charset=utf-8
content-length35445
accept-rangesbytes
cache-controlmax-age=0, s-maxage=86400
content-encodinggzip
dateThu, 19 Sep 2024 21:14:33 GMT
etag"2da1b-62269b0086973-gzip"
last-modifiedWed, 18 Sep 2024 19:19:40 GMT
server
set-cookie164 Characters
strict-transport-securitymax-age=31536000; includeSubDomains
varyAccept-Encoding,User-Agent
x-content-type-optionsnosniff
x-dispatcherdispatcher1useast1-b80
x-frame-optionsSAMEORIGIN
x-vhostpublish
x-cacheMiss from cloudfront
via1.1 adc51edbb4dc468fb382e40b115a2f62.cloudfront.net (CloudFront)
x-amz-cf-popFRA60-P1
x-amz-cf-idRTMBwhQIyqYx97qVdUdcxfT0ZtAjb_rXmc80cA7PqKacxKFvp4tUzQ==
statuscode200
http_versionHTTP/2

External factors

Blacklists
(Nice to have)
This website is not classified "for adult only".
This website has excellent links from other websites.
This page has backlinks from 355 referring domains.
This page has 14,887 backlinks.
This page has backlinks from 222 different ip addresses.
Facebook popularity
(Somewhat important)
The page has 0 shares and comments on Facebook.

Links from Wikipedia

No links from Wikipedia were found.

Robots.txt

# Ivy Robots file to be renamed as robots.txt
User-agent: *
Disallow: /search-results*
Disallow: /page-not-found*
Disallow: /system-error*
Disallow: /jcr*
Disallow: /generatepdf*
Disallow: /api/*
Disallow: /thank-you*
Disallow: /cost*
Disallow: /content/usergenerated/content/forms/af/*
Sitemap: https://www.botoxone.com/sitemap.xml

Search preview

www.botoxone.com
HOME | BOTOX ONE® | BOTOX® (onabotulinumtoxinA)
Welcome to BOTOX ONE®. We're committed to helping your practice serve patients by offering the tools and resources you and your staff need. Click here for full Safety and Prescribing Information, including Boxed Warning

Most important keywords

Following keywords were found. You can check the keyword optimization of this page for each keyword.

KeywordResultRecheck
BOTOX86%Check
BOTOX ONE80%Check
ONE71%Check
BOTOX injection64%Check
Botox Treatment62%Check
Botox Injections62%Check
received BOTOX62%Check
Patient61%Check
patients59%Check
Information59%Check

Test up to 1.000 webpages of botoxone.com with our free plan!

Try For Free
No trial. It's just free!

Cookie Policy

We use cookies to make our site work and also for analytics and advertising purposes. You can enable or disable optional cookies as desired. See the following links for more information.

We need these so the site can function properly

So we can better understand how visitors use our website

So we can serve you tailored ads and promotions